JPRN-UMIN000012816招募中未知
The effect of azilsartan on excercise capacity in hypertensive patients with sarcopenia - The effect of azilsartan on excercise capacity in hypertensive patients with sarcopenia
Geriatric medicine and nephrology, Osaka university Graduate school of medicine0 个研究点目标入组 40 人开始时间: 2014年1月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) The subjects found difficult to perform functional therapy because of prior stroke or orthopedic disease. (2) The subjects who have past medical history of hypersensitivity to azilsartan or amlodipine (3) The subjects found offensive by attending physicians for this research
研究者
相似试验
尚未招募
3 期
The effect of acetazolamide on athletic performance at heightHypoxia.IRCT20170326033146N6Razi University14
进行中（未招募）
不适用
Effect of an ACE inhibitor on the exercise capacity of COPD patients. A randomized double-blind placebo-controlled study - Effect of an ACE inhibitor on the exercise capacity of COPD patientsPATIENTS AFFECTED BY COPDMedDRA version: 9.1Level: SOCClassification code 10038738EUCTR2009-009074-27-ITPROF. ALFREDO CHETTA
已完成
不适用
Spironolactone and exercise capacity in older peopleISRCTN03869290niversity of Dundee (UK)120
已完成
不适用
The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection FractionHeart Failure With Preserved Ejection FractionNCT01505179University of California, San Diego10
进行中（未招募）
不适用
Effect of Spironolactone on Exercise Capacity in functionally impaired older people without heart failure: a double blind placebo controlled trial - Spironolactone and exercise capacity in older peopleOlder people with impairment in activities of daily living (sarcopenia)MedDRA version: 9.1Level: LLTClassification code 10063024Term: SarcopeniaEUCTR2008-002373-12-GBniversity of Dundee120